Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma - Lara-Morga, C.; Palka-Kotlowska, M.; Custodio-Cabello, S.; Pacheco-Barcia, V.; Cabezón-Gutiérrez, L. (Exploration of Targeted Anti-tumor Therapy, 2023)